Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China flag China · Delayed Price · Currency is CNY
21.61
+0.38 (1.79%)
Feb 6, 2026, 3:00 PM CST

SHA:605033 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
867.12881.01694.02905.41841.93562.54
Other Revenue
4.524.525.010.630.565.98
871.63885.53699.03906.05842.49568.52
Revenue Growth (YoY)
13.47%26.68%-22.85%7.54%48.19%10.24%
Cost of Revenue
628.39654.14478.04528.82532.38368.03
Gross Profit
243.25231.39220.99377.23310.11200.49
Selling, General & Admin
155.4141.19119.27153.18116.761.48
Research & Development
84.9374.3358.5380.0463.8151.36
Other Operating Expenses
7.322.232.753.452.92.26
Operating Expenses
241.26212.51178.09242.66187.05115.47
Operating Income
1.9818.8842.9134.57123.0685.02
Interest Expense
-0.03-0.01-0.38-0.98-3.31-0.85
Interest & Investment Income
8.649.336.586.862.613.51
Currency Exchange Gain (Loss)
0.020.020-0.060.01
Other Non Operating Income (Expenses)
-1.29-0.15-0.13-0.110.08-0.1
EBT Excluding Unusual Items
9.3228.0748.97140.34122.587.59
Gain (Loss) on Sale of Investments
0.280.47--0.07--
Gain (Loss) on Sale of Assets
-0.04-0.04-0.04-0.12-0.02-0.1
Asset Writedown
3.9900.01---
Other Unusual Items
9.359.3513.4712.2116.351.89
Pretax Income
22.937.8662.41152.37138.8389.39
Income Tax Expense
-6.8714.857.2813.0910.65
Net Income
29.7836.8657.56145.09125.7478.73
Net Income to Common
29.7836.8657.56145.09125.7478.73
Net Income Growth
-2.82%-35.96%-60.33%15.38%59.70%3.25%
Shares Outstanding (Basic)
136137134136110101
Shares Outstanding (Diluted)
136137134136110101
Shares Change (YoY)
1.18%1.99%-1.29%22.93%9.27%1.93%
EPS (Basic)
0.220.270.431.071.140.78
EPS (Diluted)
0.220.270.431.071.140.78
EPS Growth
-3.95%-37.21%-59.81%-6.14%46.15%1.30%
Free Cash Flow
55.75121.59131.117.12-215.2813.17
Free Cash Flow Per Share
0.410.890.980.13-1.950.13
Dividend Per Share
0.1500.1450.1500.2200.190-
Dividend Growth
-23.08%-3.33%-31.82%15.79%--
Gross Margin
27.91%26.13%31.61%41.63%36.81%35.27%
Operating Margin
0.23%2.13%6.14%14.85%14.61%14.95%
Profit Margin
3.42%4.16%8.23%16.01%14.92%13.85%
Free Cash Flow Margin
6.40%13.73%18.75%1.89%-25.55%2.32%
EBITDA
22.0839.3163.77150.05135.5495.49
EBITDA Margin
2.53%4.44%9.12%16.56%16.09%16.80%
D&A For EBITDA
20.120.4320.8715.4712.4810.47
EBIT
1.9818.8842.9134.57123.0685.02
EBIT Margin
0.23%2.13%6.14%14.85%14.61%14.95%
Effective Tax Rate
-2.64%7.78%4.78%9.43%11.92%
Revenue as Reported
871.63885.53699.03906.05842.49568.52
Advertising Expenses
-17.210.7827.3311.568.17
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.